Clinical laboratory parallels in women with polycystic ovary syndrome (PCOS) and metabolic syndrome (MS)

Sheeza, K.; Scientific Supervisor:  Artyomenko, V.

dc.contributor.author	Sheeza, K.
dc.contributor.author	Scientific Supervisor: Artyomenko, V.
dc.date.accessioned	2025-02-10T08:24:47Z
dc.date.available	2025-02-10T08:24:47Z
dc.date.issued	2024
dc.identifier.citation	Sheeza K. Clinical laboratory parallels in women with polycystic ovary syndrome (PCOS) and metabolic syndrome (MS). Сучасні теоретичні та практичні аспекти клінічної медицини для здобувачів освіти другого (магістерського) рівня [електронне видання] : наук.-практ. конф. з міжнар. участю, присвячена 95-річчю з дня народження Ю. Л. Курака, Одеса, 25–26 квітня 2024 року : тези доп. – Одеса : ОНМедУ, 2024. – P. 95-96.	uk_UA
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/16888
dc.description.abstract	PCOS (polycystic ovarian syndrome) in Women rates up to 33% prevalence of Metabolic Syndrome (MS). Worldwide, the prevalence of MS is associated with T2DM and obesity but some regional variations are reported as well. This condition is usually associated with long term consequences such as CVS, T2DM, psychological issues, cancer and sleep apnea. During the study, we evaluated 53 women, revealing Exceeded BMI 30kg/m2. Out of 53, in 13 patients diagnoses were T2DM, in 16 Insulin Resistance, in 22 Arterial Hypertension, in 17 increased triglycerides and in 23 reduced HDL levels among MS criteria.	uk_UA
dc.language.iso	en	uk_UA
dc.subject	polycystic ovarian syndrome	uk_UA
dc.subject	metabolic syndrome	uk_UA
dc.title	Clinical laboratory parallels in women with polycystic ovary syndrome (PCOS) and metabolic syndrome (MS)	uk_UA
dc.type	Article	uk_UA